Permission to Use

The COPD Assessment Test (CAT)

For Healthcare Professionals & Researchers

Not a healthcare professional/researcher? Visit our public site

For Healthcare Professionals & Researchers

Not a healthcare professional/researcher? Visit our public site

Permission to Use

• Please visit Mapi Research Trust’s (MRT) website (link below) to request permission to use the CAT.

• Once re-directed, click on the dark blue “Submit a Request” button on the ribbon at the top right of the page.

• There is no cost to submit a request for use.

• Enter required details and someone from MRT will contact you within 3 business days to arrange a license agreement.

• Academics and non-profits will not be charged a copyright license fee.

https://eprovide.mapi-trust.org/instruments/copd-assessment-test

The COPD Assessment Test was developed by a multi-disciplinary group of international experts in COPD supported by GSK. GSK activities with respect to the COPD Assessment Test are overseen by a Governance Board that includes independent external experts, one of whom chairs the Board.

The COPD Assessment Test is made available by GSK for the benefit of patients and their healthcare providers. For information on how you can reproduce the COPD Assessment Test free-of-charge for research purposes, please read the Terms of Use.

Please read the Terms of Use and Privacy Notice.

GlaxoSmithKline Services Unlimited. Registered in England. Company No. 01047315. Registered office: 79 New Oxford Street, London, United Kingdom, WC1A 1DG.

C/09/136. Date of preparation: August 2022. NX-GBL-CPU-WCNT-220001